All-trans retinoic acid and Arrhythmias - a phase IV clinical study of FDA data

Summary:

Arrhythmias is reported only by a few people who take All-Trans Retinoic Acid.

The phase IV clinical study analyzes which people take All-trans retinoic acid and have Arrhythmias. It is created by eHealthMe based on reports of 201 people who have side effects while taking All-trans retinoic acid from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 24, 2022

201 people reported to have side effects when taking All-trans retinoic acid.
Among them, 3 people (1.49%) have Arrhythmias.


What is All-trans retinoic acid?

All-trans retinoic acid has active ingredients of tretinoin. eHealthMe is studying from 202 All-trans retinoic acid users for its effectiveness, alternative drugs and more.

What is Arrhythmias?

Arrhythmias (irregular heartbeat) is found to be associated with 4,205 drugs and 4,500 conditions by eHealthMe.

Number of All-trans retinoic acid and Arrhythmias reports submitted per year:

Could All-trans retinoic acid cause Arrhythmias?

Gender of people who have Arrhythmias when taking All-trans retinoic acid *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Arrhythmias when taking All-trans retinoic acid *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 100 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides All-trans retinoic acid *:

  1. Trisenox: 3 people, 100.00%

Common side effects people have besides Arrhythmias *:

  1. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 100.00%
  2. Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 3 people, 100.00%
  3. Hypoxic-Ischaemic Encephalopathy (condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total): 3 people, 100.00%
  4. Haemorrhage Intracranial (bleeding within the skull): 3 people, 100.00%
  5. Bleeding Disorders: 3 people, 100.00%
  6. Bacteraemia (presence of bacteria in the blood): 3 people, 100.00%
  7. Acute Kidney Failure: 3 people, 100.00%
  8. Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 2 people, 66.67%
  9. Pulmonary Haemorrhage (acute bleeding from the lung): 2 people, 66.67%
  10. Hypotension (abnormally low blood pressure): 2 people, 66.67%

* Approximation only. Some reports may have incomplete information.

Do you take All-trans retinoic acid and have Arrhythmias?

Check whether Arrhythmias is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Arrhythmias and when was it recovered:

Expand to all the drugs that have ingredients of tretinoin:

Alternative drugs to, pros and cons of All-trans retinoic acid:

Arrhythmias treatments and more:

COVID vaccines that are related to Arrhythmias:

Common drugs associated with Arrhythmias:

All the drugs that are associated with Arrhythmias:

Common conditions associated with Arrhythmias:

All the conditions that are associated with Arrhythmias:

How the study uses the data?

The study uses data from the FDA. It is based on tretinoin (the active ingredients of All-trans retinoic acid) and All-trans retinoic acid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: